RLMD stock

Relmada Therapeutics Inc’s latest rating changes from various analysts
Daniel Torres
Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $86735.0 on ...

Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $86735.0 on ...